Commonwealth Equity Services’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Commonwealth Equity Services’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,011	Closed	-$4K	–	2413
2016 Q3	$4K	Hold	1,011	–	–	﹤0.01%	2250
2016 Q2	$3K	Buy	+1,011	New	+$4.64K	﹤0.01%	2237
2014 Q1	–	Sell	-1,011	Closed	-$19K	–	2090
2013 Q4	$19K	Hold	1,011	–	–	﹤0.01%	1912
2013 Q3	$16K	Buy	+1,011	New	+$11.7K	﹤0.01%	1856

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Commonwealth Equity Services's CTIC Position: Q4 2016 in Review

Commonwealth Equity Services sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2016, closing a stake of 1,011 shares — an estimated $4K sold.

Commonwealth Equity Services first reported a position in CTIC in Q3 2013 and held it in 4 quarters. The position peaked at $19K in Q4 2013. 58 funds tracked by Wall St. Rank hold CTIC as of Q4 2016.

Commonwealth Equity Services reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2016 after selling out during the quarter.
Commonwealth Equity Services sold 1,011 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2016, an estimated $4K.
Commonwealth Equity Services first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q3 2013 and held it in 4 quarters.
Commonwealth Equity Services's CTI BioPharma Corp. (DE) Common Stock position peaked at $19K in Q4 2013.
58 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2016.

Based on Commonwealth Equity Services's 13F filing for Q4 2016, filed 1 Feb 2017.